Adia Nutrition Inc. Introduces Cherry Payment Plans at Adia Med Clinics, Enhancing Access to Innovative Therapies
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/254843_20fd8c0b94a8a960_001full.jpg
The Cherry Payment Plans enable patients to spread treatment costs over manageable monthly installments, reducing financial barriers to accessing transformative therapies that can enhance their overall well-being. This initiative underscores Adia Nutrition's commitment to ensuring advanced treatments are within reach for those seeking to improve their personal vitality and appearance.
"Launching Cherry Payment Plans is a pivotal step toward making our therapies more inclusive," said Larry Powalisz, Chief Executive Officer of Adia Nutrition. "We believe every patient deserves access to innovative care, and these flexible payment options empower more individuals to experience the potential of treatments at Adia Med."
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/254843_20fd8c0b94a8a960_002full.jpg
Adia Med of Winter Park, which opened in January 2025, is part of a rapidly expanding clinical network dedicated to personalized care. Patients can explore Cherry Payment Plans to enhance affordability. Those interested in treatment options or financing are encouraged to fill out the contact form at www.adiamed.com.
For questions, inquiries, or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
A quick reminder: Adia Nutrition Inc. is presenting live today, June 11th, at 2:00 PM EST at the Life Sciences Virtual Investor Forum, hosted by VirtualInvestorConferences.com.
About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.comWebsite: www.adiamed.com Website: www.adialabs.comWebsite: www.biolete.comWebsite: www.cementfactory.coTwitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254843
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
a day ago
- Miami Herald
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
Broadcast Premieres Saturday, July 12 at 6:30 PM EST on Bloomberg Television NEW YORK CITY, NY / ACCESS Newswire / July 12, 2025 / New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, airing Saturday, July 12 at 6:30 PM EST. Episode #678 showcases five transformative companies leading advancements across artificial intelligence, healthcare, sustainability, and blockchain. This dynamic lineup brings powerful insights from visionary leaders shaping the future of their respective industries. Featured Segments in Episode #678: Hapbee Technologies (OTCQB:HAPBF)NBA All-Star Jaylen Brown shares how Hapbee's groundbreaking wearable neurotech helps optimize sleep, recovery, and cognitive performance-without pharmaceuticals. The device uses proprietary low-frequency signals to emulate the effects of popular compounds, empowering users to choose how they feel, naturally and safely. Arrive AI (NASDAQ:ARAI)Live from Nasdaq MarketSite in Times Square, host Ana Berry interviews CEO Dan O'Toole and Chief Strategy Officer Neerav Shah as they unveil Arrive's secure smart mailbox technology. Phase 1 launches in healthcare and logistics; Phase 2 expands to every U.S. ZIP code. Arrive beat Amazon to the patent by four days, reinforcing its first-mover advantage in the $150B+ last-mile delivery sector. FLOKI (CRYPTO:FLOKI)Pedro Vidal, FLOKI's Community Relations Officer, discusses the explosive success of Valhalla, its play-to-earn metaverse game. As FLOKI expands across DeFi, NFTs, and blockchain gaming, its highly engaged global community cements it as one of crypto's most disruptive and culturally relevant brands. Learn more at BioVie Inc. (NASDAQ:BIVI)CEO Cuong Do and Chief Medical Officer Joseph Palumbo join Jane King to share meaningful updates on BioVie's advancement in clinical trials targeting Alzheimer's, Parkinson's, and Long COVID. BioVie is the only company to receive a federal grant to study Long COVID, and is currently enrolling patients in a 200‑person clinical trial. They also introduce Social Impact Partners, a nonprofit initiative to foster collaboration across the private, public, and government sectors in supporting Alzheimer's patients. The segment touches on promising new research around BioVie's investigational drug Bezisterim, which may reduce cellular "rust buildup"-a key contributor to aging. Initial findings suggest it could play a role in slowing the aging process. The Sustainable Green Team (OTC:SGTM)CEO Tony Raynor outlines how SGTM transforms organic landfill waste into premium garden and soil products. What began as a mulch and tree removal business is now a regenerative brand with Amazon-ready offerings and national retail ambitions. SGTM is on a mission to restore soil health across America. Learn more at This episode is presented as sponsored programming on Bloomberg Television, reaching more than 124 million households nationwide. Further distribution includes: New to The Street's YouTube channel with 3 million+ subscribersEarned media coverage across major networksIconic outdoor billboards in Times Square and major U.S. metros Sponsors for Episode #678 include MUSQ, and Arrive AI TV Commercials. Media Contact:Monica BrennanNew to The Street - Media RelationsMonica@ Watch & Learn More: SOURCE: New to The Street
USA Today
a day ago
- USA Today
New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
Broadcast Premieres Saturday, July 12 at 6:30 PM EST on Bloomberg Television New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, airing Saturday, July 12 at 6:30 PM EST. Episode #678 showcases five transformative companies leading advancements across artificial intelligence, healthcare, sustainability, and blockchain. This dynamic lineup brings powerful insights from visionary leaders shaping the future of their respective industries. Featured Segments in Episode #678: Hapbee Technologies (OTCQB:HAPBF) NBA All-Star Jaylen Brown shares how Hapbee's groundbreaking wearable neurotech helps optimize sleep, recovery, and cognitive performance-without pharmaceuticals. The device uses proprietary low-frequency signals to emulate the effects of popular compounds, empowering users to choose how they feel, naturally and safely. Arrive AI (NASDAQ:ARAI) Live from Nasdaq MarketSite in Times Square, host Ana Berry interviews CEO Dan O'Toole and Chief Strategy Officer Neerav Shah as they unveil Arrive's secure smart mailbox technology. Phase 1 launches in healthcare and logistics; Phase 2 expands to every U.S. ZIP code. Arrive beat Amazon to the patent by four days, reinforcing its first-mover advantage in the $150B+ last-mile delivery sector. FLOKI (CRYPTO:FLOKI) Pedro Vidal, FLOKI's Community Relations Officer, discusses the explosive success of Valhalla, its play-to-earn metaverse game. As FLOKI expands across DeFi, NFTs, and blockchain gaming, its highly engaged global community cements it as one of crypto's most disruptive and culturally relevant brands. Learn more at BioVie Inc. (NASDAQ:BIVI) CEO Cuong Do and Chief Medical Officer Joseph Palumbo join Jane King to share meaningful updates on BioVie's advancement in clinical trials targeting Alzheimer's, Parkinson's, and Long COVID. BioVie is the only company to receive a federal grant to study Long COVID, and is currently enrolling patients in a 200‑person clinical trial. They also introduce Social Impact Partners, a nonprofit initiative to foster collaboration across the private, public, and government sectors in supporting Alzheimer's patients. The segment touches on promising new research around BioVie's investigational drug Bezisterim, which may reduce cellular 'rust buildup'-a key contributor to aging. Initial findings suggest it could play a role in slowing the aging process. The Sustainable Green Team (OTC:SGTM) CEO Tony Raynor outlines how SGTM transforms organic landfill waste into premium garden and soil products. What began as a mulch and tree removal business is now a regenerative brand with Amazon-ready offerings and national retail ambitions. SGTM is on a mission to restore soil health across America. Learn more at This episode is presented as sponsored programming on Bloomberg Television, reaching more than 124 million households nationwide. Further distribution includes: New to The Street's YouTube channel with 3 million+ subscribers Earned media coverage across major networks Iconic outdoor billboards in Times Square and major U.S. metros Sponsors for Episode #678 include MUSQ, and Arrive AI TV Commercials. 'We're proud to deliver this high‑impact episode featuring leaders from five of the most innovative sectors,' said Vince Caruso, Co‑Founder and Executive Producer of New to The Street. 'This show exemplifies our mission to present breakthrough companies and ideas with credibility, scale, and reach.' Media Contact: Monica Brennan New to The Street – Media Relations Monica@ Watch & Learn More: SOURCE: New to The Street View the original press release on ACCESS Newswire
Business Wire
2 days ago
- Business Wire
Jack Nathan Health Announces Its Q4 and Year End Fiscal 2025 Financial Results
TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ('Jack Nathan Health', 'JNH' or the 'Company') announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2025, and fiscal year ended January 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards ('IFRS'). Disclosure Regarding Filing Timing As previously disclosed in a press release issued on June 9, 2025, the Company was unable to file its annual financial statements, MD&A, and related CEO and CFO certifications for the fiscal year ended January 31, 2025, by the prescribed filing deadline of May 31, 2025. The delay was due to operational restructuring, resource realignment, and transition impacts following the divestiture of its Canadian primary care operations and the winding down of Mexico operations. The Company is pleased to confirm that it has now completed the filings within the 90-day permitted period, and all required documents are available on SEDAR+. Management Commentary Mike Marchelletta, Chief Executive Officer, commented: 'Fiscal 2025 was a pivotal year of transition for Jack Nathan Health. We successfully completed the divestiture of our Canadian primary care and licensee business, which significantly improved our balance sheet and eliminated legacy obligations. Following year-end, we also ceased all clinic operations in Mexico after the termination of our agreement with Walmart Mexico. With both legacy business segments now exited, our current focus is on internal restructuring, stabilizing our operations, and preserving cash while evaluating future strategic opportunities. We believe these actions have positioned the Company for a more focused path forward.' Financial Highlights for the fiscal year ended January 31, 2025 For the fiscal year ended January 31, 2025, total consolidated revenues were $19.1 million, consistent with the prior year. Revenues from continuing operations increased 26% to $8.7 million driven by the full-year contribution from MedSpa operations and the continued activity of the Mexico division through fiscal year-end. MedSpa revenues were $1.03 million, up 90% year-over-year. Discontinued operations contributed $10.4 million in revenue prior to the sale of the Canadian medical clinic and licensee business on December 1, 2024. Note on Mexico Operations: The 2025 financial statements reflect the Mexico clinic operations as part of continuing operations, as these locations were active through January 31, 2025. However, subsequent to year-end, all operations in Mexico were fully ceased as of June 30, 2025 following the formal termination of the Company's agreement with Walmart Mexico. As such, the Mexico division is no longer part of Jack Nathan Health's active business going forward. The Company reported a loss from continuing operations of $2.5 million, compared to $1.3 million in the prior year. However, discontinued operations yielded a net gain of $9.99 million, largely driven by a $16.4 million gain on the sale of the Canadian operations. Balance Sheet as of January 31, 2025 Cash of $2.2 million (January 31, 2024 - $3.06 million) Total assets of $3.54 million (January 31, 2024 - $11.19 million) Total liabilities of $2.22 million (January 31, 2024 - $17.13 million) Working capital improved to $1.4 million, compared to a working capital deficit of $0.5 million the year prior. Shares Outstanding As of January 31, 2025, the Company had 87,099,159 common shares outstanding, 1,650,000 stock options outstanding and 335,004 DSUs outstanding. For further information regarding the Company's financial results for fiscal year ended January 31, 2025, please refer to the audited annual consolidated financial statements of the Company as at and for the 12 months ended January 31, 2025 together with the corresponding MD&A, available at and the JNH website https// About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit https// or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Appendix: Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to Jack Nathan are intended to identify forward- looking information. All statements other than statements of historical fact may be forward- looking information. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties, and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political, and competitive developments; and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward- looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward- looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward- looking information, other than as required by applicable law.
